Panacea Biotec Secures Major UNICEF Vaccine Supply Deal

Panacea Biotec announced on Friday that it has secured a significant long-term supply order from UNICEF, valued at USD 35.65 million, for bivalent oral polio vaccines.

According to a regulatory filing, the company received a letter of award from UNICEF, confirming a long-term agreement to supply bOPV starting from April 1, 2026, to March 31, 2030.

The contract encompasses the supply of bOPV in 10 and 20 vial presentations to meet UNICEF's needs as specified in future orders.

(With inputs from agencies.)